echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Kyushu Tonghuo Huahai pharmaceutical irbesartan tablets with volume procurement expansion sales channels outside the scope

    Kyushu Tonghuo Huahai pharmaceutical irbesartan tablets with volume procurement expansion sales channels outside the scope

    • Last Update: 2019-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Yu yaozhi.com will learn that on November 26, kyushutong announced that it had signed a strategic cooperation framework agreement with Zhejiang Huahai Pharmaceutical Sales Co., Ltd to sell the winning variety "irbesartan tablets" of Huahai in all channels except for 4 + 7 cities with volume procurement and hospitals in Fujian and Hebei Province, which were under the pilot expansion of volume procurement organized by the state Dao's sales promotion and medical distribution guarantee in the selected provinces in the alliance procurement That is to say, except for Jiangxi, Anhui, Shandong, Shaanxi, Inner Mongolia, Jilin, Qinghai, Jiangsu, Fujian and Hebei, all regional hospitals' channel sales promotion and medical distribution guarantee in the provinces selected in the alliance procurement belong to Jiuzhoutong Irbesartan tablets are used for the treatment of type 2 diabetic nephropathy with essential hypertension and hypertension The number of drugs to be won in the "4 + 7" city is 137 million This time, Huahai pharmaceutical entrusts kyushutong to purchase in the "4 + 7" city and other hospitals in Fujian and Hebei, with the sales target of 900 million in all channels (including the number of drugs to be won in the alliance region) The agreement includes: The validity period is from November 1, 2019 to December 31, 2020 Indeed, although it is a good thing to obtain sales channels outside the bid winning area, the number of 900 million pieces actually includes the matching quota of other bid winning enterprises Apart from the remaining market of this part, how many enterprises to compete with, and even whether to surpass the local bid winning enterprises are all problems In my opinion, the significance remains to be proved Penicillin is the reprinted content of yaozhi.com, and the copyright belongs to the original author The purpose of reprinting is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.